table network network 2
demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only
COVID 19 all comersCOVID-19 mild to moderate
COVID 19 hospitalizedCOVID 19 all comersCOVID-19 mild to moderate
umifenovir (arbidol) Nojomi ELACOI ... ELACOI ...

3 studies excluded by filtering options 0

5290 UAIIC, 2021 010selection pending
5989 Yethindra, 2020 113high risk of bias
6750 Chen_arbidol, 2020 1134not a RCThigh risk of bias

 

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons